Product
pp65-shLAMP DC with GM-CSF
1 clinical trial
5 indications
Indication
Glioblastoma MultiformeIndication
GlioblastomaIndication
Malignant GliomaIndication
AstrocytomaIndication
Grade IVClinical trial
ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed GlioblastomaStatus: Completed, Estimated PCD: 2023-11-30